Good Quality L-Leucine Ep - Glycine CAS 56-40-6 for Pharma Grade(USP/EP/BP) – Honray
Good Quality L-Leucine Ep - Glycine CAS 56-40-6 for Pharma Grade(USP/EP/BP) – Honray Detail:
Usage:
Glycine (Abbreviated Gly) is one of the 20 amino acids. It is widely used in the pharmaceutical, feed and food processing industries.
As food additive, it is mainly used as flavoring, sweetener and nutritional supplement. It is also added in butter, cheese and margarine for prolonging the storage life.
As feed additive, it is added in the feed for increasing the appetites for the poultry and the domestic animals, especially for pets.
As pharmaceutical intermediate, Glycine is used as the raw material of cephalosporin, aureomycin buffer, VB6 and Threonine etc. and the intermediate of thiamphenicol . When Glycine is used in combination with aspirin, it can reduce irritation to the stomach. Glycine is also used in amino acid injection solution as nutritional infusion.
Glycine is also the main raw material for the synthesis of the herbicide Glyphosate.
1. Tech-Grade
(1) Used as a solvent for removing CO2 in the fertilizer industry, as an additive to the galvanizing solution.
(2) Used as a PH regulator
(3) Used as a key raw material for Herbicide Glyphosate.
2. Food/Feed Grade
(1) Used as a flavoring, sweetener and nutritional supplement. Applied in alcoholic beverage, animal and plant food processing, for the making of salted vegetables and sweet jams.
(2) As an additive for the making of salted sauce, vinegar and fruit juice, in order to improve the flavor and the taste of food and increase the nutrition of food.
(3) As a preservative for fish flakes and peanut jams and stabilizer for cream, cheese etc.
(4) As a buffering agent for the taste of edible salt and vinegar.
(5) Used as a feed additive to increase the appetites for the poultry and the domestic animals, especially for pets.
3.Pharm Grade
(1) Used in amino acid injection solution as nutritional infusion.
(2) Used as a supplemental medicine to treat myasthenia progressive and pseudo hypertrophic muscular dystrophy.
(3) Used as acid-making agent to treat neural hyperacidity and gastric ulcer hyperacidity.
Specifications
| ITEM | EP7.0 | BP2007 | USP39 | |
| Appearance | White crystalline powder | White crystalline powder | — | |
| Appearance of solution | clear | clear | — | |
| Identification test(first A, second B,C) | A | Up to S. | Up to S. | — |
| B | Up to S. | Up to S. | ||
| C | Up to S. | Up to S. | ||
| Identification test (Infrared spectrum test) | — | — | Up to S. | |
| Ninhydrin-positive substances | Up to S. | — | Up to S. | |
| Assay | 98.5-101.0% | 98.5-101.0% | 98.5-101.5% | |
| Chloride | ≤0.0075% | ≤0.0075% | ≤0.007% | |
| Heavy metals(as Pb) | ≤0.001% | ≤0.001% | ≤0.002% | |
| Sulfate | — | — | ≤0.0065% | |
| PH Value | 5.9 ～ 6.4 | 5.9 ～ 6.4 | — | |
| Loss on drying | ≤0.5% | ≤0.5% | ≤0.2% | |
| Residue on ignition | — | — | ≤0.1% | |
| Readily hydrolysable substances | — | — | Up to S. | |
Product detail pictures:
Related Product Guide:
We can easily normally satisfy our respected buyers with our excellent high-quality, excellent selling price and good service due to we've been far more expert and more hard-working and do it in cost-effective way for Good Quality L-Leucine Ep - Glycine CAS 56-40-6 for Pharma Grade(USP/EP/BP) – Honray , The product will supply to all over the world, such as: Gambia, Ukraine, Mexico, We believe that good business relationships will lead to mutual benefits and improvement for both parties. We've got established long-term and successful cooperative relationships with many customers through their confidence in our customized services and integrity in doing business. We also enjoy a high reputation through our good performance. Better performance might be expected as our principle of integrity. Devotion and Steadiness will remain as ever.
By Dolores from Serbia - 2018.10.09 19:07
High Quality, High Efficiency, Creative and Integrity, worth having long-term cooperation! Looking forward to the future cooperation!
By Christopher Mabey from Boston - 2018.12.05 13:53
